ATLANTA – Alcohol-mediated renal denervation (RDN) showed a “modest but significant” decrease in 24-hour ambulatory systolic blood pressure compared to a sham procedure at 3 months, meeting the primary endpoint, according to TARGET BP I randomized trial results.